Select Page

Lataro RM, Moraes DJA, Gava FN, Omoto ACM, Silva CAA, Brognara F, Alflen L, Brazão V, Colato RP, do Prado JC Jr, Ford AP, Salgado HC, Paton JFR published a paper entitled, ‘P2X3 receptor antagonism attenuates the progression of heart failure’.

Nature Communications. 2023 Mar 28;14(1):1725. doi: 10.1038/s41467-023-37077-9.

The latest press release on this paper outlines how sleep apnoea can be alleviated by drugs, and thereby potentially slow the progression of heart failure. The results of this paper are promising as currently there is no pharmacotherapy available for the condition.

Read the paper